多发性硬化患病率与社会人口学、卫生系统及生活方式因素在国家与区域层面的关联
本研究为生态学研究,利用多边组织和科学文献数据,评估年龄和性别调整后的多发性硬化患病率与社会人口学、卫生系统、神经科特异性及生活方式因素的关联。单变量回归显示国家层面除肥胖和吸烟外所有因素均显著相关;多变量分析中人均卫生支出(β=0.083,95%CI 0.048-0.12,p<0.01)和纬度(β=1.05,95%CI 0.63-1.47,p<0.01)仍显著关联。作者认为人均卫生支出与全国多发性硬化患病率强相关,提示仅归因于纬度对维生素D影响的学说并不完整。
要点
- 国家层面单变量回归中,除肥胖患病率和吸烟外,所有调查因素均与多发性硬化患病率显著相关。
- 多变量分析中,人均卫生支出(β=0.083,95%CI 0.048-0.12,p<0.01)和纬度(β=1.05,95%CI 0.63-1.47,p<0.01)仍显著关联。
- 作者认为卫生保健可及性显著贡献于全球多发性硬化患病率差异,低卫生支出国家可能显著低估患病率。
核心结论
- 人均卫生支出与全国多发性硬化患病率强相关,提示将患病率差异主要归因于纬度对维生素D影响的学说并不完整。
- 卫生保健可及性显著贡献于全球多发性硬化患病率差异,尤其因国家财富随纬度升高,低卫生支出国家可能显著低估患病率。
研究设计与样本
- 生态学研究,使用多边组织和科学文献数据,评估年龄和性别调整后的多发性硬化患病率与预设因素的关联。
- 预设因素包括社会人口学(人均国内生产总值、人均国民总收入)、卫生系统(人均当前卫生支出及占GDP百分比、全民健康覆盖指数、人均医生数)、神经科特异性(MRI设备密度、人均神经科医生数)和生活方式(肥胖、烟草使用)。
- 汇总国家、区域和收入分层数据,采用相关单变量和多变量回归模型,并以逐步变量选择技术识别独立预测因子。
主要发现
- 国家层面单变量回归分析显示,除肥胖患病率和烟草使用外,所有调查因素均与多发性硬化患病率显著相关。
- 纬度在所有世界区域均与多发性硬化患病率显著相关(β=0.16-2.16),全民健康覆盖指数在6个世界区域中的5个显著相关(β=0.18-3.17)。
- 在高收入国家,多发性硬化患病率与除生活方式因素和MRI设备密度外的所有因素显著相关,但在低收入国家未观察到任何关联。
- 纬度与多发性硬化患病率在除低收入国家外的所有收入分层中相关(β=0.55-1.62)。
- 多变量分析中,人均当前卫生支出(β=0.083,95%CI 0.048-0.12,p<0.01)和纬度(β=1.05,95%CI 0.63-1.47,p<0.01)仍与多发性硬化患病率显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Multiple sclerosis (MS) prevalence varies widely by country and world region, variation that is often attributed to latitude and its association with vitamin D exposure. Given that increasing latitude is also associated with higher national wealth, this study investigated associations between MS prevalence and other factors driving regional differences, with a focus on sociodemographic, health systems, and lifestyle factors on a national and regional level. METHODS: Using data from multilateral organizations and scientific literature, an ecological study was conducted to evaluate associations between age- and sex-adjusted MS prevalence and prespecified sociodemographic (gross domestic product [GDP] per capita and gross national income [GNI] per capita), health systems (current health expenditure per capita and by percentage of GDP, universal health coverage [UHC] index, and medical doctors per capita), neurology-specific (MRI unit density and neurologists per capita), and lifestyle (obesity and tobacco use) factors. National, regional, and income-stratified data were aggregated and employed in relevant univariable and multivariable regression models. Stepwise variable selection techniques identified independent predictors of MS prevalence. RESULTS: Univariable regression analyses showed significant associations at the national level for all investigated factors, except obesity prevalence and tobacco use. Latitude was significantly associated with MS prevalence in all world regions (β = 0.16-2.16), whereas the UHC index was significantly associated in 5 of 6 world regions (β = 0.18-3.17). MS prevalence was significantly associated with all factors except lifestyle factors and MRI unit density in high-income countries, but no associations were observed in low-income countries. Latitude was associated with MS prevalence for all income strata except low-income countries (β = 0.55-1.62). In multivariable analyses, current health expenditure per capita (β = 0.083, 95% CI 0.048-0.12, p < 0.01) and latitude (β = 1.05, 95% CI 0.63-1.47, p < 0.01) remained significantly associated with MS prevalence. DISCUSSION: Health expenditure per capita is strongly associated with national MS prevalence, suggesting that theories that attribute variations in MS prevalence primarily to latitude effects on vitamin D are incomplete. Health care access significantly contributes to the global variations in MS prevalence, especially since national wealth rises with latitude and likely results in significant underestimation of MS prevalence in countries with lower health expenditure.
引用
- Hwang S, Garcia-Dominguez MA, Fitzgerald KC, et al. Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level. Neurology. 2022. PMID: 36002320. doi:10.1212/WNL.0000000000200962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。